Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID‐19 vaccination: a prospective cohort study in healthcare workers
Pawinee Rerknimitr, Thanaporn Puaratanaarunkon, Chanidapa Wongtada, N. Wittayabusarakam, Saran Krithin, Leilani Paitoonpong, Chanat Kumtornrut, Stephen J. Kerr, P. Asawanonda, Watsamon Jantarabenjakul, Jettanong Klaewsongkram
Abstract
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Health careSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVaccinationCohortAdverse effectProspective cohort studyVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)EconomicsEconomic growthDermatological and COVID-19 studiesSARS-CoV-2 and COVID-19 ResearchGenital Health and Disease